Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2

Published:2014-06-04 Issue:9 Volume:63 Page:877-888
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Xie Wei,Li Daojuan,Zhang Juan,Li Zhike,Acheampong Desmond Omane,He Yuan,Wang Youfu,Chen Zhiguo,Wang Min

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-014-1560-9.pdf

Reference33 articles.

1. Ozato K, Mayer N, Sachs DH (1980) Hybridoma cell lines screting monoclonal antibodies to mouse H-2 and la antigens. J Immunol 124(2):533–540

2. Yagami H, Kato H, Tsumoto K, Tomita M (2013) Monoclonal antibodies based on hybridoma technology. Pharm Pat Anal 2(2):249–263

3. Dubrot J, Portero A, Orive G, Hernández RM, Palazón A, Rouzaut A, Perez-Gracia JL, Hervás-Stubbs S, Pedraz JL, Melero I (2010) Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells. Cancer Immunol Immunother 59(11):1621–1631

4. Tjandra JJ, Ramadi L, McKenzie IF (1990) Development of human anti-murine antibody (HAMA) response in patients. Immunol Cell Biol 68(6):367–376

5. Azinovic I, DeNardo GL, Lamborn KR, Mirick G, Goldstein D, Bradt BM, DeNardo SJ (2006) Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies. Cancer Immunol Immunother 55(12):1451–1458

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A VEGFR2–MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice;Cancer Immunology, Immunotherapy;2019-08-19

2. The bispecific antibody HB-32, blockade of both VEGF and DLL4 shows potent anti-angiogenic activity in vitro and anti-tumor activity in breast cancer xenograft models;Experimental Cell Research;2019-07

3. Anti-CD24 Antibody–Nitric Oxide Conjugate Selectively and Potently Suppresses Hepatic Carcinoma;Cancer Research;2019-03-27

4. Combination of Anti-angiogenics and Other Targeted Therapies;Tumor Angiogenesis;2019

5. A Novel Fusion Antibody Exhibits Antiangiogenic Activity and Stimulates NK Cell-mediated Immune Surveillance Through Fused NKG2D Ligand;Journal of Immunotherapy;2017-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3